Hide
Brief description of measure
CMS159: Depression Remission at Twelve Months:
The percentage of adolescent patients 12 to 17 years of age and adult patients 18 years of age or older with major depression or dysthymia who reached remission 12 months (+/- 60 days) after an index event
Description of issue
The measure developer proposes removing the exclusion for patients who are permanent nursing home residents. Many facilities that offer skilled nursing care do so for patients with a transitional need, recovery after hospital stay or procedure. According to the National Quality Forum's guidance around the use of exclusion in a measure, an exclusion or exception needs to be of sufficient volume that without then the result would be significantly distorted. Data demonstrates low usage - 0.07% - of this exclusion based on statewide Minnesota data collection analysis of exclusions in over 140,000 patients.
Based on this, it is expected that removing this exclusion will have very minimal to no impact on the measure.
Goal of review
Obtain clinical and technical feedback
Show
Brief description of measure
CMS159: Depression Remission at Twelve Months:
The percentage of adolescent patients 12 to 17 years of age and adult patients 18 years of age or older with major depression or dysthymia who reached remission 12 months (+/- 60 days) after an index event
Description of issue
The measure developer proposes removing the exclusion for patients who are permanent nursing home residents. Many facilities that offer skilled nursing care do so for patients with a transitional need, recovery after hospital stay or procedure. According to the National Quality Forum's guidance around the use of exclusion in a measure, an exclusion or exception needs to be of sufficient volume that without then the result would be significantly distorted. Data demonstrates low usage - 0.07% - of this exclusion based on statewide Minnesota data collection analysis of exclusions in over 140,000 patients.
Based on this, it is expected that removing this exclusion will have very minimal to no impact on the measure.
Goal of review
Obtain clinical and technical feedback